Pfizer’s Ex-Chief Regulatory Counsel Joins DLA Piper (Correct)

March 22, 2021, 11:01 AM UTCUpdated: March 22, 2021, 1:53 PM UTC

DLA Piper has hired veteran pharmaceutical industry lawyer Geoffrey Levitt to serve as co-chair of its expanding life sciences and health policy and regulatory group, an offering that will help the firm target clients in an increasingly important sector.

Levitt, who will be based in Washington, worked for Pfizer Inc. for more than a decade, serving as chief regulatory counsel. He most recently was head of international affairs and policy for Viatris Inc., and also was chief counsel for Pfizer Inc.'s Upjohn division in China.

DLA Piper Chair Frank Ryan told Bloomberg Law last month the firm views life sciences ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.